Clinical, trichoscopic, and folliscopic identification of the impact of metabolic syndrome on the response to intradermal dutasteride 0.02% injection in patients with female pattern hair loss: a prospective cohort study.

Background: No studies investigating the impact of metabolic syndrome (MetS) in treatment response of female pattern hair loss (FPHL).

Objective: In this prospective cohort study, we studied the impact of MetS in response to intradermal dutasteride 0.02% injection in patients with FPHL.